Company intelligence / Profile preview
Quivive Pharma
San Diego, California, United Statesquivivepharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Quivive Pharma has demonstrated proof-of-concept in animal studies and is advancing its lead product, QEV‑817—a fixed-dose combination of hydrocodone bitartrate and doxapram hydrochloride—into Phase 1 clinical trials. The company’s approach aims to reduce opioid-induced respiratory depression without compromising analgesia, offering both safety improvements and abuse deterrence. Clinical results are pending as the first-in-human study is not yet recruiting as of March 2025.
- Therapeutic areas
- PulmonologyNeurology
- Modalities
- Small molecules (specifically fixed-dose combinations of generic opioids and respiratory stimulants)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Camargo Pharmaceutical Services (regulatory consulting & strategic development services for pipeline development under the US FDA’s Section 505(b)(2) pathway)
Beyond the preview
Go deeper on Quivive Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Quivive Pharma.